|
SKCHEM is a South Korean chemical and life sciences company operating through Green Chemicals and Life Science business segments. The Green Chemicals segment produces high-functionality copolyester resins, DMT, coating and adhesive polyester resins, bio-based polyols, and chemically recycled PET, serving customers in the automotive, electronics, packaging, and construction industries across Asia, Europe, and the Americas. Key product brands include SKYGREEN, ECOZEN, ECOTRIA, SKYDMT, SKYBON, SKYPURA, SKYPEL, SKYTRA, PO3G, and SKYPET CR. The Life Science segment develops and markets pharmaceuticals, including natural medicine-based arthritis treatments, blood circulation improvers, and transdermal patches, alongside its subsidiary SK Bioscience, which manufactures vaccines and provides CDMO services. SKCHEM also operates SK Multiutility, a subsidiary that supplies steam and electricity to industrial zones. The company maintains production facilities in South Korea and China, with regional offices in the United States, Germany, Japan, and Malaysia. Notable partnerships include a joint development agreement with Sanofi for a 21-valent pneumococcal vaccine and the acquisition of IDT Biologika, a German CDMO provider. The company was founded in 1969. Summarised from the company's own disclosures, fiscal year ended Mar 2026 |
Industry Specialty Chemicals | Homepage skchemicals.com |
| Sector Basic Materials | IR page skchemicals.com/ir | |
|
Tags
copolyester resins, chemical recycling, bio-based polyols, pharmaceuticals, vaccines, cdmo, industrial energy supply, adhesive resins, thermoplastic elastomers, SKYGREEN, ECOZEN, ECOTRIA, SKYDMT, SKYBON, SKYPURA, SKYPEL, SKYTRA, PO3G, SKYPET CR, Joins, Ginkxin F, Rivastigmine Patch, Emvix S, Trast, SK Bioscience, IDT Biologika, SK Multiutility, Shuye, RIC
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | ₩ 1.124T |
| Market cap (USD) | $ 827.304M |
| P/E | 156.91 |
| PEG | — |
| P/BV | 0.46 |
| P/S | 0.43 |
| P/OCF | 7.34 |
| P/FCF | -6.34 |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 2.0% |
| ROI | 2.0% |
| ROIC | >-0.01% |
| Profit margin | 1.9% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -38.4% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | — |
| Quality score | -5.9% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.365T | 1.737T | 1.749T | 1.829T | 2.09T | 1.215T | 1.427T | 1.368T | 87.836B |
| Net profit | 44.646B | 8.839B | 39.864B | 191.266B | 168.14B | 254.321B | 10.597B | 6.028B | -8.536B |
| Free cash flow | -149.204B | -511.441B | -229.782B | -476.683B | 371.129B | — | -4.538B | -14.572B | -19.157B |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | |||||||||
| Trade receivables (KRW) | 204B | 196B | 171B | 233B | 367B | 260B | 180B | 368B | 343B |
| ↳ YoY growth | -4.2% | -12.6% | +36.1% | +57.3% | -29.0% | -30.7% | +104.2% | -7.0% | |
| ↳ 5y CAGR | +5.0% | -1.6% | +16.6% | +8.0% | |||||
| Borrowings, current (KRW) | 404B | 326B | 440B | 205B | 11.7B | 436B | 264B | 430B | 478B |
| Borrowings, non-current (KRW) | 229B | 181B | 72.9B | 31.1B | — | 7.17B | 473B | 1.2T | 1.66T |
| Bonds payable (KRW) | — | — | — | — | — | 155B | 165B | 219B | 466B |
| Lease liabilities (KRW) | 5.97B | 4.94B | 58.5B | 12.4B | 11.1B | 24.9B | 16.7B | 24.5B | 22.8B |
| Cash and deposits (KRW) | 155B | 45.3B | 184B | 86.8B | 256B | 400B | 396B | 542B | 568B |
| Intangible assets (KRW) | 47.4B | 38.3B | 37.4B | 37B | 44.4B | 51.8B | 54.2B | 163B | 228B |
| Right-of-use assets (KRW) | — | — | 58.2B | 16.1B | 15.4B | 28.6B | 35.3B | 45.3B | 42.4B |
| Net debt (borrowings + leases - cash) (KRW) | 478B | 461B | 388B | 161B | -233B | 68.1B | 357B | 1.12T | 1.59T |
| Cash flow detail | |||||||||
| Operating cash flow (KRW) | -10.7B | 67.4B | 122B | 247B | 509B | -187B | 146B | -89.3B | 236B |
| Purchases of property, plant and equipment (KRW) | -8.49B | -81.9B | -127B | — | -138B | -288B | -376B | -422B | -385B |
| Purchases of intangible assets (KRW) | -301M | -2.56B | -3.17B | -2.31B | -6.65B | -12.6B | -10.7B | -18.2B | -81.3B |
| Dividends paid (cash effect) (KRW) | — | — | -5.28B | -6.01B | -26.1B | -67.2B | -29.9B | -17.6B | -22.5B |
| Share buybacks (cash effect) (KRW) | — | -1.32B | — | -4.43B | -3.17B | -50B | 0.00 | 0.00 | — |
| Interest paid (cash effect) (KRW) | -2.28B | -31.2B | -33B | -24.4B | -14.7B | -17.6B | -29.6B | -39.7B | -47.9B |
| Income taxes paid (cash effect) (KRW) | -111M | -3.72B | -19.2B | -21.1B | -107B | -185B | -51B | — | — |
| Free cash flow (OCF - PPE - intangibles) (KRW) | -19.5B | -17.1B | -7.7B | — | 364B | -487B | -241B | -530B | -230B |
| Income detail | |||||||||
| Total comprehensive income (KRW) | -10B | -18.3B | 985M | 252B | 268B | 246B | -24.2B | 86.2B | 94.7B |
| Comprehensive income to owners (KRW) | -8.78B | 4.36B | 6.59B | 251B | 169B | 203B | -12.7B | 66.6B | 74.4B |
| Reported | Mar 30, 2020 | Aug 19, 2019 | Mar 30, 2020 | Apr 28, 2021 | Mar 18, 2024 | Mar 18, 2025 | Mar 18, 2025 | Mar 18, 2025 | Mar 19, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpDisclosures filed with DART (material events and exchange disclosures), newest first, headlines as filed in Korean. The link opens the filing on DART. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding SKCHEM
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVEE | 0.03% | 1,174 | $ 34.07K | Nov 16, 2026 |
| DEXC | 0.01% | 711 | $ 21.296K | Nov 12, 2026 |
| DFEV | 0.01% | 4,337 | $ 129.903K | Nov 12, 2026 |
| DFSE | 0.00% | 587 | $ 17.582K | Nov 12, 2026 |
| DFEM | 0.00% | 8,954 | $ 268.193K | Nov 12, 2026 |
| DFAE | 0.00% | 4,982 | $ 149.222K | Nov 12, 2026 |
| DFAX | 0.00% | 3,625 | $ 108.577K | Nov 12, 2026 |
| AVEM | 0.00% | 25,070 | $ 727.537K | Nov 16, 2026 |
| AVSE | 0.00% | 298 | $ 8,648.03 | Nov 16, 2026 |
| AVXC | 0.00% | 531 | $ 15.41K | Nov 16, 2026 |